课题基金 / 基金详情

Targeting mTOR to restore mucosal immunity toward remission in HIV-infected individuals

Targeting mTOR to restore mucosal immunity toward remission in HIV-infected individuals
靶向 mTOR 恢复 HIV 感染者的粘膜免疫以缓解病情
批准号：
365728
负责人：
Ancuta Petronela
金额：
$18.21万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-02-01 至 2018-08-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=365728&lang=en
关键词：
Cd4+ T-Cells Flow Cytometry Genome-Wide Transcriptional Profiling Hiv Reservoirs Hiv-1 Mammalian Target Of Rapamycin Microscopy Mucosal Immunity Rna Interference Th17 Cells

项目摘要

项目成果

Ancuta Petronela的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Although antiretroviral therapy (ART) transformed HIV-1 infection into a manageable chronic disease, HIV remains a major health problem, with more than 36 million infected people worldwide and 2 million new infections in 2014. In Canada, new infections co
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Finding the Perfect Time to Hunt for HIV: A Tale of 36 Hours at the CHUM
Identification of Aryl Hydrocarbon Receptor as a Novel Druggable Modulator of HIV-1 Latency
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
The Th17 Master Regulator RORC2 as a New Target for HIV Immune Therapy and Cure Strategy
海外基金